Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02104427
Title PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors TaiGen Biotechnology Co., Ltd.
Indications

multiple myeloma

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

Burixafor

Filgrastim

Age Groups: adult
Covered Countries USA


No variant requirements are available.